152 related articles for article (PubMed ID: 27879275)
1. Von Willebrand Factor and ADAMTS13: Too Much or Too Little of a Good Thing?
Emmer BT; Ginsburg D; Desch KC
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2281-2282. PubMed ID: 27879275
[No Abstract] [Full Text] [Related]
2. Binding of ADAMTS13 to von Willebrand factor.
Majerus EM; Anderson PJ; Sadler JE
J Biol Chem; 2005 Jun; 280(23):21773-8. PubMed ID: 15824096
[TBL] [Abstract][Full Text] [Related]
3. Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus.
Domingueti CP; Dusse LM; Fóscolo RB; Reis JS; Annichino-Bizzacchi JM; Orsi FL; Mazetto Bde M; Carvalho Md; Gomes KB; Fernandes AP
PLoS One; 2015; 10(7):e0132784. PubMed ID: 26168189
[TBL] [Abstract][Full Text] [Related]
4. The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.
Zhao B; Li J; Luo X; Zhou Q; Chen H; Shi H
Tex Heart Inst J; 2011; 38(5):516-22. PubMed ID: 22163125
[TBL] [Abstract][Full Text] [Related]
5. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13.
Zheng X; Nishio K; Majerus EM; Sadler JE
J Biol Chem; 2003 Aug; 278(32):30136-41. PubMed ID: 12791682
[TBL] [Abstract][Full Text] [Related]
6. High levels of von Willebrand factor and low levels of its cleaving protease, ADAMTS13, are associated with stroke in young HIV-infected patients.
Allie S; Stanley A; Bryer A; Meiring M; Combrinck MI
Int J Stroke; 2015 Dec; 10(8):1294-6. PubMed ID: 26121272
[TBL] [Abstract][Full Text] [Related]
7. Changes in von Willebrand factor and ADAMTS13 during IVF.
Westerlund E; Antovic A; Hovatta O; Eberg KP; Blombäck M; Wallén H; Henriksson P
Blood Coagul Fibrinolysis; 2011 Mar; 22(2):127-31. PubMed ID: 21192251
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS13 and microvascular thrombosis.
Tsai HM
Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):813-25. PubMed ID: 17173498
[TBL] [Abstract][Full Text] [Related]
9. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
10. Single particle tracking of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type-1 repeats) molecules on endothelial von Willebrand factor strings.
De Ceunynck K; Rocha S; De Meyer SF; Sadler JE; Uji-i H; Deckmyn H; Hofkens J; Vanhoorelbeke K
J Biol Chem; 2014 Mar; 289(13):8903-15. PubMed ID: 24550384
[TBL] [Abstract][Full Text] [Related]
11. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13.
Bowen DJ; Collins PW
Blood; 2004 Feb; 103(3):941-7. PubMed ID: 14525793
[TBL] [Abstract][Full Text] [Related]
12. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
Reiter RA; Knöbl P; Varadi K; Turecek PL
Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
[TBL] [Abstract][Full Text] [Related]
13. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
[TBL] [Abstract][Full Text] [Related]
14. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
15. Production, crystallization and preliminary crystallographic analysis of an exosite-containing fragment of human von Willebrand factor-cleaving proteinase ADAMTS13.
Akiyama M; Takeda S; Kokame K; Takagi J; Miyata T
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Jul; 65(Pt 7):739-42. PubMed ID: 19574655
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.
Akiyama M; Takeda S; Kokame K; Takagi J; Miyata T
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19274-9. PubMed ID: 19880749
[TBL] [Abstract][Full Text] [Related]
17. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
18. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.
Sonneveld MA; de Maat MP; Leebeek FW
Blood Rev; 2014 Jul; 28(4):167-78. PubMed ID: 24825749
[TBL] [Abstract][Full Text] [Related]
19. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
[TBL] [Abstract][Full Text] [Related]
20. Degradation of platelet-von Willebrand factor complexes by plasmin: an alternative/backup mechanism to ADAMTS13.
Chauhan AK
Circulation; 2014 Mar; 129(12):1273-5. PubMed ID: 24449820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
